Stock Events

Stock Events

Kalaris Therapeutics (KLRS) Q2 2026 Earnings

12MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-2.52

-1.83

-1.15

-0.46

Details

Expected EPS

-0.523333

Actual EPS

-0.46

Surprise EPS

0.06

Surprise Percent

+12.1%

Description

Kalaris Therapeutics (KLRS) has reported earnings of -0.46 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.